key: cord-0709651-hed4nmr9
authors: Hintschich, Constantin A.; Wenzel, Jürgen J.; Hummel, Thomas; Hankir, Mohammed K.; Kühnel, Thomas; Vielsmeier, Veronika; Bohr, Christopher
title: Psychophysical tests reveal impaired olfaction but preserved gustation in COVID‐19 patients
date: 2020-07-01
journal: Int Forum Allergy Rhinol
DOI: 10.1002/alr.22655
sha: 4fb9819aa7d6a8aebe913346f57ced3ad84883d9
doc_id: 709651
cord_uid: hed4nmr9

nan

To the Editor,

The current COVID-19 pandemic is challenging healthcare systems and societies worldwide in an unprecedented way. Unspecific symptoms including fever and cough are frequently observed and serve as indicators for home quarantine and molecular testing by PCR 1 . Interestingly, sudden dysfunctions in smell and taste have been described, first anecdotally, and then in retrospective reports 2, 3 . These pathognomonic symptoms have led to the consensus that olfactory and gustatory defects should equally be regarded as highly suspicious for SARS-CoV-2 infection, even in the absence of other symptoms 4 . Due to home quarantine and the short duration of chemosensitive disorders, reports so far have mostly been retrospective. Psychophysical tests of olfactory and gustatory function have mainly been performed in hospitalized patients only 5 .

Here, we report on a controlled prospective trial enrolling COVID-19 patients from southeast Germany to objectively assess complaints of smell and taste loss using reliable and validated psychophysical tests. Respiratory samples of all subjects were tested positive for the presence of SARS-CoV-2 RNA by RT-qPCR in the diagnostic unit of our tertiary care hospital. Patients under home quarantine were contacted directly after a positive result had been reported. Following informed consent, participants were sent both a 4-item smell test ("Pocket Smell Test"; Sensonics, USA) and a 4-item taste test ("Taste Strips"; taste qualities of sweet, sour, salty, and bitter; Burghart Messtechnik, Germany). A combined online manual and questionnaire ensured correct self-administration and queried subjective smell and taste. In the case of a suspected pregnancy, the bitter strip was skipped to prevent possible adverse effects through quinine hydrochloride. Hyposmia and hypogeusia respectively were defined as ≥1 incorrect answer. Statistical analysis was done by Fisher's exact test (SPSS, version 26.0, SPSS, USA). p < 0.05 was regarded as significant.

A total of 41 (median age 37 years, 68% female, 32% male) patients answered the online questionnaire and self-administered the olfactory and gustatory tests in median 5 days after the positive SARS-CoV-2 PCR result and 13 days after the first symptoms. As shown in Table 1 , 25 (61%) and 18 (44%) patients described a current hyposmia and hypogeusia, respectively. This is in line with previous reports 6 . There was no case of isolated hypogeusia whereas 28% of patients reported isolated hyposmia. The control group consisted of 30 patients (median age 33 years, 73% female, 27% male) who tested negative for IgG antibodies against SARS-CoV-2. In comparison, the subjective loss in smell and taste occurred significantly more often in COVID-19 patients (61% vs.

10%, p<0.0001; 44% vs. 10%, p=0.0003; see Table 1 ). SARS-CoV-2 infection was significantly associated with a positive test for hyposmia but not hypogeusia (54% vs. 27%, p=0.03; 20% vs. 10%.

p=0.34; see Table 1 ). In COVID-19 patients, the subjective loss in smell was confirmed by a hyposmic test result in 72% whereas the subjective loss in taste was confirmed by a hypogeusic test in only 33%. Within the group of SARS-CoV-2 positive patients, there was a tight dependence between subjective ratings of smell dysfunction and hyposmia in the olfactory test (44%, p=0.005; see Table   2 ). This was not the case for subjective ratings of taste function and gustatory testing (15%, p=0.11; see Table 2 ).

In conclusion, these results demonstrate that a high proportion of COVID-19 patients describe a loss of taste. However, in contrast with prior publications, standardized functional testing of the gustatory modalities of sweet, sour, salty and, bitter did not reveal a bona fide hypogeusia. The subjectively altered taste is most likely caused by impaired retronasal olfaction 4 . To the best of our knowledge, this controlled prospective trial shows for the first time that COVID-19 is tightly associated with olfactory loss but not with gustatory dysfunction when tested psychophysically. 

It is therefore possible that hyposmia directly relates to SARS-CoV-2 infection severity. Further research is needed to confirm these findings in a larger cohort of COVID-19 patients and to better understand how SARS-CoV-2 impacts the olfactory pathway

Institute of Clinical Microbiology and Hygiene

Smell & Taste Clinic, Department of Otorhinolaryngology

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms

Presentation of new onset anosmia during the COVID-19 pandemic

Olfactory Dysfunction in COVID-19: Diagnosis and Management

Smell dysfunction: a biomarker for COVID-19

The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis